Pricing Log in Create free account

Alzamend Neuro, Inc. (ALZN) vs Alaunos Therapeutics, Inc. (TCRT)

Alzamend Neuro, Inc. and Alaunos Therapeutics, Inc. are both Biotechnology companies. Alzamend Neuro, Inc. and Alaunos Therapeutics, Inc. are of similar size ($6.4M and $6.2M). Across the 10 metrics below, Alzamend Neuro, Inc. leads on 7 and Alaunos Therapeutics, Inc. on 3.

Valuation

Metric ALZN TCRT Biotechnology median
P/E n/m n/m 8.50
P/S n/m 456.87 9.71
P/B 1.02 9.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 n/m 0.64
EV/Sales n/m 1,552.30 9.21
Earnings yield (174.24%) (72.62%) (33.15%)
Free cash flow yield (120.83%) (20.65%) (25.50%)

Profitability

Metric ALZN TCRT Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.23%) (185.95%) (56.36%)
Return on assets (122.36%) (128.30%) (48.04%)
Return on invested capital 0.00% (480.35%) 0.00%

Growth

Metric ALZN TCRT Biotechnology median
Revenue growth (TTM) — (17.65%) 6.02%
EPS growth (last fiscal year) 76.77% 24.66% 30.26%
Revenue growth, 5-year CAGR — (49.08%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALZN TCRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.01 0.77 4.72
Net debt to EBITDA 0.08 0.33 0.96

Dividend

Metric ALZN TCRT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALZN TCRT Biotechnology median
Market cap 6.17m 6.38m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack